Hong Kong – September 23, 2026 -- Ping An Good Doctor (HKEX: 1833) said its AI business accounted for approximately 4.6% of gross profit in the first half of 2026, as the Hong Kong-listed insurer's healthcare arm shifts from diagnostic AI tools toward services that execute care plans on the ground.
Ping An launches AI-powered home rehab coaching
The company upgraded its Ping An AI Doctor service with Ping An Smart Private Coach, a hybrid AI-and-coaching offering that tracks 34 points on the body to deliver real-time feedback across seven categories, including posture correction, chronic-pain rehabilitation, postpartum recovery and Baduanjin qigong exercise. The global market for AI personal trainers is projected to grow from $16.9 billion in 2025 to $65.7 billion by 2033, a trend coinciding with China's National Health Commission "Weight Management Year" initiative launched in 2024.
Ping An GlobalCare targets rising foreign visitor volumes in China
Ping An Good Doctor unveiled Ping An GlobalCare at the Shenzhen Sci-Tech Innovation Exhibition, timed to China's expanded visa-free entry policies; government data show foreign national entries exceeded 60 million in the first eight months of 2026. Now piloted in Shenzhen, the platform supports registration via phone numbers issued in 198 countries and regions and includes an AI medical-translation engine covering 19 languages.
Case coordinators turn AI triage into three-hour hospital visits
In one company-reported case, a U.S. user with acute abdominal pain completed an AI-translated online triage session. A case coordinator then arranged transport and guided him through hospital registration and diagnostic tests, with the company reporting the full process completed within three hours.
AI-physician mechanism covers all retail customers, report shows
Ping An Good Doctor's 2026 Interim Report states its "AI + Physician" collaboration mechanism covers 100% of Ping An Group's retail customers, supported by the company's proprietary multimodal model, Ping An Medical Master®. Frost & Sullivan's 2026 Blue Book on the Development of the Global AI Healthcare Industry frames this shift as medical AI moving from isolated diagnostic tools toward integrated systems combining data, medical knowledge and clinical workflows.